Phase 1

Phase 1

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

67 Clinical Trials
Phase 1 Phase I/II Accepting Patients
nct/study# NCT03110107 / CA022-001

Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

Learn More
Phase 1 Phase I/II Accepting Patients
nct/study# NCT03400332 / CA027-002

A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

Learn More
Phase 1 Phase I/II Accepting Patients
nct/study# NCT03369223 / CA030-001

A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors

Learn More
Phase 1 Phase I/II Accepting Patients
nct/study# NCT03994601 / CA043-001

A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors

Learn More
Phase 1 Phase I/II Accepting Patients
nct/study# NCT04895709 / CA052-002

A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination with Nivolumab in Participants with Advanced Solid Tumors

Learn More
Phase 1 I Active
nct/study# SET101

A Phase 1/1b, Open-Label Multi-Center Two Part Study Of Setd2 Inhibitor Ezm0414 In Subjects With Relapsed/Refractory Multiple Myeloma And Relapsed/Refractory Diffuse Large B Cell Lymphoma

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.